Defeating anaemia in myelodysplastic syndromes: another step forward with Luspatercept
Prof. Valeria Santini, in her article published on Lancet Oncology, presents the clinical study of dr. Uwe Platzbecker focused on MDS low risk patient treated with a new drug: Luspatercept.
Here there is a video of Prof. Santini interviewed by Pharmastar during the last EHA Congress in Madrid ( June 2017): she talks about Luspatercept.